David Bredt

Founder at Rapport Therapeutics, Inc.

59 year

Health Technology

Commercial Services

Profile

David Bredt is the founder of Rapport Therapeutics, Inc., which was founded in 2022.
He held the title of Director & Chief Scientific Officer.
Currently, Dr. Bredt is a Director at CONNECT.
In the past, he worked as a Vice President at Eli Lilly & Co.

David Bredt active positions

Companies	Position	Start
CONNECT CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA.	Director/Board Member	-
Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	Founder	31/01/2022

All active positions of David Bredt

Former positions of David Bredt

Companies	Position	End
ELI LILLY AND COMPANY	Corporate Officer/Principal	-

See the detail of David Bredt's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Bredt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ELI LILLY AND COMPANY	Health Technology

Private companies	2
CONNECT CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA.	Commercial Services
Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	Health Technology